IFP Advisors, Inc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6
-99.9%
30
-9.1%
0.00%
Q3 2022$7,0000.0%330.0%0.00%
Q2 2022$7,000
-12.5%
33
-10.8%
0.00%
Q1 2022$8,000
+700.0%
37
+825.0%
0.00%
Q4 2021$1,0000.0%40.0%0.00%
Q3 2021$1,0000.0%40.0%0.00%
Q2 2021$1,0000.0%4
-20.0%
0.00%
Q1 2021$1,0005
+25.0%
0.00%
Q4 2020$0
-100.0%
4
-88.6%
0.00%
Q3 2020$3,000
-25.0%
350.0%0.00%
Q2 2020$4,000
-60.0%
35
-72.9%
0.00%
-100.0%
Q1 2020$10,000
-37.5%
129
-15.7%
0.00%0.0%
Q4 2019$16,000
-44.8%
153
-50.5%
0.00%
-50.0%
Q3 2019$29,000
+222.2%
309
+382.8%
0.00%
+100.0%
Q4 2018$9,000
-35.7%
64
+25.5%
0.00%0.0%
Q3 2018$14,000
+16.7%
51
-15.0%
0.00%0.0%
Q2 2018$12,000
+9.1%
60
-27.7%
0.00%
Q1 2018$11,0000.0%830.0%0.00%
Q4 2017$11,000
-65.6%
83
-64.2%
0.00%
-100.0%
Q3 2017$32,000
+6.7%
232
-4.5%
0.00%0.0%
Q2 2017$30,000
-18.9%
243
-29.8%
0.00%
-50.0%
Q1 2017$37,000
+362.5%
346
+316.9%
0.00%
Q4 2016$8,000
-27.3%
83
-19.4%
0.00%
-100.0%
Q3 2016$11,000
-31.2%
103
-21.4%
0.00%0.0%
Q2 2016$16,000
+14.3%
131
+4.8%
0.00%0.0%
Q4 2015$14,0001250.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders